Bionique Testing Laboratories Completes Expansion

Bionique Testing Laboratories LLC, a subsidiary of Asahi Kasei and mycoplasma testing services specialist for the life science industry, has completed its newly expanded facility in Saranac Lake, NY.

The investment expands service capabilities through ~35,000 sq.-ft. of laboratory and support spaces—more than triple the size of the original facility.  With the state-of-the-art facility expansion, Bionique will provide comprehensive testing solutions and validation services across the entire drug development lifecycle, focusing on integrating advanced technologies to respond to evolving industry needs and regulatory acceptance of rapid biosafety analytical testing solutions.

The new footprint features purpose-built labs designed for mycoplasma, sterility, endotoxin, and viral testing method development and processing. It also includes flexible containment labs and BSL capabilities to meet diverse modality needs across biologics, cell and gene therapies, and advanced therapeutics. The expansion increases capacity for high-volume, CGMP-compliant lot-release workflows with optimized sample logistics and throughput.

“This facility investment is about an expanded service offering,” said Gladis Zamparo, CEO at Bionique. “For decades, customers have trusted Bionique for critical lot-release testing. Our expansion ensures we broaden our capabilities and digital experience, while maintaining accelerated turnaround times—so our partners can release safe products faster. “